Trexo Theo
Trexo Robotics, Inc. · Decision date Sep 2, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Trexo Theo, a powered lower extremity exoskeleton from Trexo Robotics, Inc., under 21 CFR 890.3480, Class II, product code PHL, in the Physical Medicine specialty. The decision date is September 2, 2026; the public record lists the application as received December 23, 2025, while the clearance letter cites a July 31, 2026 dated submission received August 3, 2026. SESE is a 510(k) clearance, not a PMA approval.
The summary describes a battery-powered, wearable lower-limb exoskeleton assisting hip and knee motion, used with a rigid, four-wheeled, lockable walker frame and controlled by a trained operator through a tablet. Named predicates are Cyberdyne's HAL-ML (K233695) and Rewalk P6.0 (K221696). The stated indication covers ambulatory functions in patients 12 years and older with cerebral palsy, in community and clinical settings under certified supervision, and excludes sports and stair climbing. The record does not resolve the differing submission dates or provide independent clinical findings.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Sep 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254198
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Trexo Robotics, Inc.
- Product code
- PHL
- Decision code
- SESE
- Decision date
- Sep 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Powered Exoskeleton.
- Applicant
- Trexo Robotics, Inc.
- Product code
- PHL
- FDA device class
- 2
FDA decision timeline
K254198 received
Application receipt date recorded by FDA.
K254198 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Trexo Robotics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Mississauga
Sources and methodology
- Original FDA record: K254198
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records